Radiation Medicine Centre, Bhabha Atomic Research Centre, TMH Annexe Building, Parel, Mumbai, 400012, India.
Homi Bhabha National Institute , Bhabha Atomic Research Centre, Mumbai, India.
J Endocrinol Invest. 2022 Apr;45(4):731-739. doi: 10.1007/s40618-021-01697-z. Epub 2021 Nov 10.
This study presents a case of familial transmission of thyroxine-binding globulin (TBG) deficiency. The SERPINA7-gene which codes for TBG is located on the X-chromosome (Xq21-22). More than 45 mutations have been reported to cause TBG- deficiency from various countries, but none from India so far. Genetic analysis of SERPINA7 gene was carried out to determine the cause of low TBG levels in one family.
DNA samples of the propositus and the family members were subjected to Polymerase Chain Reaction (PCR) followed by direct sequencing. Allele-specific PCR and Next-gen sequencing (NGS) were employed to confirm the site of the mutation. Thyroid function tests were estimated by Radioimmunoassay (RIA) and Immunoradiometric assay (IRMA) kits. X-chromosomal inactivation status was analyzed in the female members harboring the mutation.
A mutational screening in this family revealed a novel frame-shift mutation S353Q, 354fs3X in the exon 4 of the SERPINA7 gene which will be referred to as TBG-complete deficiency-India (TBG-CD-Ind). One out of four female family members harboring the mutation showed selective X-chromosomal inactivation. The affected family members were clinically euthyroid initially, showed changes in the thyroid function when tested after a long time span. However, the changes in the thyroid function in the affected family members had an autoimmune etiology.
This study presents the first report of TBG-CD from India wherein a novel frameshift mutation referred to as TBG-CD-Ind (S353Q, 354fs3X) in the SERPINA7 gene was detected. No apparent association was identified between thyroid function and the TBG-mutation in the affected subjects. A detailed biochemical and genomic testing to determine the exact cause of discordant TFT in the patients would certainly aid in the unequivocal diagnosis of the thyroid function and for the precise individualized treatment.
本研究报告了一例甲状腺素结合球蛋白(TBG)缺陷的家族性传递病例。编码 TBG 的 SERPINA7 基因位于 X 染色体(Xq21-22)上。来自不同国家的报道已经发现超过 45 种突变会导致 TBG 缺陷,但迄今为止还没有来自印度的报道。对 SERPINA7 基因进行了基因分析,以确定一个家族中 TBG 水平低的原因。
对先证者及其家庭成员的 DNA 样本进行聚合酶链反应(PCR),然后直接测序。等位基因特异性 PCR 和下一代测序(NGS)用于确认突变的位置。采用放射免疫测定(RIA)和免疫放射测定(IRMA)试剂盒测定甲状腺功能。对携带突变的女性成员进行 X 染色体失活状态分析。
在这个家族中进行的突变筛查发现了一个新的移码突变 S353Q,354fs3X,位于 SERPINA7 基因的外显子 4 中,将其称为 TBG 完全缺陷-印度(TBG-CD-Ind)。携带突变的 4 名女性家庭成员中有 1 名表现出选择性 X 染色体失活。受影响的家庭成员最初表现为临床甲状腺功能正常,随着时间的推移,甲状腺功能发生了变化。然而,受影响的家族成员的甲状腺功能变化具有自身免疫病因。
本研究首次报道了来自印度的 TBG-CD,在 SERPINA7 基因中发现了一种新的移码突变,称为 TBG-CD-Ind(S353Q,354fs3X)。在受影响的受试者中,未发现甲状腺功能与 TBG 突变之间存在明显关联。详细的生化和基因组检测将有助于确定患者不一致的 TFT 的确切原因,从而明确诊断甲状腺功能,并为个体化治疗提供准确依据。